An experimental drug called DT-109 reversed severe fatty liver disease in animal studies by repairing the gut and preventing harmful toxins from damaging the liver. The discovery could open the door ...

Two new rapid tests, EndoSure and Endotest, can drastically reduce the wait time for a proper diagnosis of endometriosis—from an average nine-year wait to just days. The saliva test just approved for ...

If you’ve ever had bloodwork done, you know that understanding the clinical terms and lab values can feel like reading a ...

Over the past decades, some medical researchers and neuroscientists have been exploring the possible therapeutic effects of ...

Quest is the largest reference laboratory to embed oncology molecular ordering into OncoEMR MPI, with projected reach to 4,700 clinicians across ~1,600 community oncology sites. Integration targets ...

Prescribing antidepressants according to biological markers may improve response rates. | Drug Discovery And Development ...

For decades, treating depression has largely involved a difficult form of medical guesswork: prescribing one antidepressant ...

JPMorgan Chase unveiled a new $50 billion share repurchase program and raised its quarterly dividend after passing the Federal Reserve's annual stress test. JPMorgan said it will increase its ...

Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Read more about the events that may impact stock prices next week. Elevated options ...

Neumora Therapeutics said on ‌Monday it would stop developing its ​depression drug after ​two late-stage trials failed ⁠to meet their ​main goals.

Rocket Lab posted its strongest quarter ever in Q1 of 2026, with revenue reaching $200 million. This 63.5% year-over-year increase is an impressive growth rate for a company that did slightly more ...

The American Cancer Society (ACS) has updated its guidelines for colorectal cancer screening. The organization released the update in its flagship journal on Wednesday, noting that the new ...